Literature DB >> 16642883

Primary TKA with a zirconia ceramic femoral component.

B Sonny Bal1, David D Greenberg, Luke Buhrmester, Thomas J Aleto.   

Abstract

This article presents the 2-year clinical results of primary total knee arthroplasty (TKA) performed with a zirconia ceramic femoral component. A posterior-stabilized TKA was performed for degenerative arthritis in 36 patients (39 knees). The components included a zirconia femoral component, a cobalt-chrome alloy tibial baseplate, and a polyethylene patella; all were implanted with bone cement. The ultra-high molecular-weight polyethylene-bearing insert had a deep-dish, ultra-congruent design. At the 2-year interval, mean Western Ontario and McMaster Universities (WOMAC) osteoarthritis indices improved from 41 to 86, and mean Knee Society Scores improved from 40 to 92. Revision to constrained implants was necessary in one patient for persistent knee instability after trauma. These early results are encouraging, but more data are needed to determine whether ceramics are a suitable alternative to metal countersurfaces in TKAs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642883     DOI: 10.1055/s-0030-1248085

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  3 in total

1.  Designing prosthetic knee joints with bio-inspired bearing surfaces.

Authors:  Mingfeng Qiu; Anthony Chyr; Anthony P Sanders; Bart Raeymaekers
Journal:  Tribol Int       Date:  2014-09-01       Impact factor: 4.872

2.  Patients' perspective on controversial issues in total knee arthroplasty.

Authors:  Tae Kyun Kim; Jinbae Choi; Kwang Sook Shin; Chong Bum Chang; Sang Cheol Seong
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-12-22       Impact factor: 4.342

3.  Alternative bearings in total knee arthroplasty: risk of early revision compared to traditional bearings: an analysis of 62,177 primary cases.

Authors:  Maria C S Inacio; Guy Cafri; Elizabeth W Paxton; Steven M Kurtz; Robert S Namba
Journal:  Acta Orthop       Date:  2013-03-14       Impact factor: 3.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.